Michael Crowley Biography and Net Worth

Michael Crowley is Executive Vice President - Global Commercial Operations of the Company. He was appointed Executive Vice President, Global Commercial Operations in December 2014. Previously he was Vice President, Commercial Manager, Europe from 2012 to 2014 and Commercial Manager, Clinical Diagnostics Group, Europe from 2011 to 2012 and Division Manager of the Clinical Diagnostics Group North American Sales Organization from 2008 to 2011. Prior to that, he was the Clinical Diagnostics U.S. National Sales Manager since joining Bio-Rad in 1998.

What is Michael Crowley's net worth?: The estimated net worth of Michael Crowley is at least $1.93 million as of February 27th, 2024. Mr. Crowley owns 6,942 shares of Bio-Rad Laboratories stock worth more than $1,930,154 as of April 24th. This net worth approximation does not reflect any other assets that Mr. Crowley may own. Learn More about Michael Crowley's net worth.
How do I contact Michael Crowley?: The corporate mailing address for Mr. Crowley and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected]. Learn More on Michael Crowley's contact information.
Has Michael Crowley been buying or selling shares of Bio-Rad Laboratories?: Michael Crowley has not been actively trading shares of Bio-Rad Laboratories during the last ninety days. Most recently, Michael Crowley sold 3,000 shares of the business's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $336.00, for a transaction totalling $1,008,000.00. Following the completion of the sale, the executive vice president now directly owns 6,942 shares of the company's stock, valued at $2,332,512. Learn More on Michael Crowley's trading history.
Who are Bio-Rad Laboratories' active insiders?: Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), Ronald Hutton (VP), Giovanni Magni (EVP), Ajit Ramalingam (CAO), and Annette Tumolo (EVP). Learn More on Bio-Rad Laboratories' active insiders.
Are insiders buying or selling shares of Bio-Rad Laboratories?: In the last twelve months, insiders at the medical research company sold shares 7 times. They sold a total of 8,190 shares worth more than $2,870,551.60. The most recent insider tranaction occured on February, 27th when EVP Michael Crowley sold 3,000 shares worth more than $1,008,000.00. Insiders at Bio-Rad Laboratories own 17.5% of the company. Learn More about insider trades at Bio-Rad Laboratories.
Information on this page was last updated on 2/27/2024.

Michael Crowley Insider Trading History at Bio-Rad Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/27/2024	Sell	3,000	$336.00	$1,008,000.00	6,942
11/28/2023	Sell	642	$305.10	$195,874.20	6,942
6/15/2023	Sell	500	$379.39	$189,695.00	6,040
8/9/2021	Sell	3,000	$754.93	$2,264,790.00	6,669
12/15/2020	Sell	374	$580.67	$217,170.58	3,669
6/1/2020	Sell	1,500	$485.40	$728,100.00	2,310
9/4/2019	Sell	1,089	$333.08	$362,724.12	2,011
12/14/2018	Sell	392	$248.03	$97,227.76	3,425
12/4/2017	Sell	1,000	$258.39	$258,390.00	2,492
8/11/2017	Sell	700	$215.91	$151,137.00	2,060
3/7/2017	Sell	300	$196.13	$58,839.00	2,760

Michael Crowley Buying and Selling Activity at Bio-Rad Laboratories

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Today's Range

Now: $278.04

$277.36

$285.27

50 Day Range

MA: $327.31

$278.04

$351.99

2 Week Range

Now: $278.04

$261.59

$473.50

Volume

209,104 shs

Average Volume

203,730 shs

Market Capitalization

$7.93 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87

The #1 Biotech Stock to Have on Your Radar in 2024…

From Huge Alerts | Ad

Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!

Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now!